Viral infection-oxidative stress/DNA damage-aberrant DNA methylation: Separate or interrelated events responsible for genetic instability and childhood ALL development?

Biochimica et Biophysica Acta - Reviews on Cancer

Volumn 1846, Issue 1, 2014, Pages 226-231

  Olinski, Ryszard ^a   Styczynski, Jan ^a   Olinska, Elwira ^b   Gackowski, Daniel ^a  

^a NICOLAUS COPERNICUS UNIVERSITY   (Poland)

^b District Health Center in Kartuzy   (Poland)

Author keywords

5 Methylcytosine; Acute lymphoblastic leukemia; Deaminases; Epigenetics; Oxidative stress; Viral infection

Indexed keywords

ACTIVATION INDUCED CYTIDINE DEAMINASE; APOLIPOPROTEIN B MESSENGER RNA EDITING ENZYME CATALYTIC POLYPEPTIDE; APOLIPOPROTEIN B MRNA EDITING ENZYME CATALYTIC POLYPEPTIDE LIKE DEAMINASE; CYTOSINE DEAMINASE; DEAMINASE; DNA; UNCLASSIFIED DRUG;

ACUTE LYMPHOBLASTIC LEUKEMIA; CANCER GROWTH; CHILDHOOD LEUKEMIA; CHROMOSOME ABERRATION; CYTOSTASIS; CYTOTOXICITY; DNA DAMAGE; DNA METHYLATION; ENZYME ACTIVITY; GENE EXPRESSION; GENETIC STABILITY; GENOME; HETEROZYGOSITY LOSS; HUMAN; INFLAMMATION; LEUKEMOGENESIS; MICROSATELLITE INSTABILITY; MOLECULAR MECHANICS; NONHUMAN; OXIDATION; OXIDATIVE STRESS; POINT MUTATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; VIRUS INFECTION;

5-METHYLCYTOSINE; ACUTE LYMPHOBLASTIC LEUKEMIA; DEAMINASES; EPIGENETICS; OXIDATIVE STRESS; VIRAL INFECTION;

ANIMALS; CELL TRANSFORMATION, NEOPLASTIC; DISEASE SUSCEPTIBILITY; DNA DAMAGE; DNA METHYLATION; EPIGENESIS, GENETIC; GENE-ENVIRONMENT INTERACTION; GENOMIC INSTABILITY; HUMANS; OXIDATIVE STRESS; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; VIRUS DISEASES;

EID: 84905234707     PISSN: 0304419X     EISSN: 18792561     Source Type: Journal    
DOI: 10.1016/j.bbcan.2014.06.004     Document Type: Review

References (61)

1. Pui C.H., Evans W.E. Acute lymphoblastic leukemia. N. Engl. J. Med. 1998, 339:605-615.
2. Pui C.H., Carroll W.L., Meshinchi S. Biology, risk stratification, and therapy of pediatric acute leukemias: an update (vol 29, pg 551, 2011). J. Clin. Oncol. 2011, 29:4847.
3. Mrozek K., Harper D.P., Aplan P.D. Cytogenetics and molecular genetics of acute lymphoblastic leukemia. Hematol. Oncol. Clin. North Am. 2009, 23:991-1010.
4. Greaves M. Infection, immune responses and the aetiology of childhood leukaemia. Nat. Rev. Cancer 2006, 6:193-203.
5. Kinlen L. Evidence for an infective cause of childhood leukemia - comparison of a Scottish New Town with nuclear reprocessing sites in Britain. Lancet 1988, 2:1323-1327.
6. Greaves M.F. Speculations on the cause of childhood acute lymphoblastic-leukemia. Leukemia 1988, 2:120-125.
7. Roman E., Simpson J., Ansell P., Kinsey S., Mitchell C.D., McKinney P.A., et al. Childhood acute lymphoblastic leukemia and infections in the first year of life: a report from the United Kingdom Childhood Cancer Study. Am. J. Epidemiol. 2007, 165:496-504.
8. Wiseman H., Kaur H., Halliwell B. DNA-damage and cancer - measurement and mechanism. Cancer Lett. 1995, 93:113-120.
9. Cooke M.S., Olinski R., Evans M.D. Does measurement of oxidative damage to DNA have clinical significance?. Clin. Chim. Acta 2006, 365:30-49.
10. Shimoda R., Nagashima M., Sakamoto M., Yamaguchi N., Takagi H., Mori M., et al. Increased formation of oxidative DNA-damage in livers with chronic hepatitis. Gastroenterology 1994, 106:A983.
11. Pacher P., Beckman J.S., Liaudet L. Nitric oxide and peroxynitrite in health and disease. Physiol. Rev. 2007, 87:315-424.
12. Coussens L.M., Werb Z. Inflammation and cancer. Nature 2002, 420:860-867.
13. Toyokuni S., Okamoto K., Yodoi J., Hiai H. Persistent oxidative stress in cancer. FEBS Lett. 1995, 358:1-3.
14. Imbesi S., Musolino C., Allegra A., Saija A., Morabito F., Calapai G., et al. Oxidative stress in oncohematologic diseases: an update. Exp. Rev. Hematol. 2013, 6:317-325.
15. Almondes K.G., de Oliveira T.F., Siviero-Miachon A.A., Lee M.L., Rondo P.H., Loureiro A.P., Spinola-Castro A.M., Cozzolino S.M. Selenium inadequacy is not associated with oxidative stress in child and adolescent acute lymphocytic leukemia survivors. Nutrition 2014, 30:563-568.
16. Dincer Y., Yuksel S., Batar B., Guven M., Onaran I., Celkan T. DNA repair gene polymorphisms and their relation with DNA damage, DNA repair, and total antioxidant capacity in childhood acute lymphoblastic leukemia survivors. J. Pediatr. Hematol. Oncol. 2014, 10.1097/MPH.0000000000000133.
17. Yang Y., Tian Y., Yan C., Jin X., Tang J., Shen X. Determinants of urinary 8-hydroxy-2'-deoxyguanosine in Chinese children with acute leukemia. Environ. Toxicol. 2009, 24:446-452.
18. Stanczyk M., Sliwinski T., Cuchra M., Zubowska M., Bielecka-Kowalska A., Kowalski M., et al. The association of polymorphisms in DNA base excision repair genes XRCC1, OGG1 and MUTYH with the risk of childhood acute lymphoblastic leukemia. Mol. Biol. Rep. 2011, 38:445-451.
19. Dziaman T., Gackowski D., Rozalski R., Siomek A., Szulczynski J., Zabielski R., et al. Urinary excretion rates of 8-oxoGua and 8-oxodG and antioxidant vitamins level as a measure of oxidative status in healthy, full-term newborns. Free Radic. Res. 2007, 41:997-1004.
20. Mori H., Colman S.M., Xiao Z.J., Ford A.M., Healy L.E., Donaldson C., et al. Chromosome translocations and covert leukemic clones are generated during normal fetal development. Proc. Natl. Acad. Sci. U. S. A. 2002, 99:8242-8247.
21. Roman-Gomez J., Jimenez-Velasco A., Agirre X., Castillejo J.A., Navarro G., Garate L., et al. Promoter hypermethylation and global hypomethylation are independent epigenetic events in lymphoid leukemogenesis with opposing effects on clinical outcome. Leukemia 2006, 20:1445-1448.
22. Wong N.C., Ashley D., Chatterton Z., Parkinson-Bates M., Ng H.K., Halemba M.S., et al. A distinct DNA methylation signature defines pediatric pre-B cell acute lymphoblastic leukemia. Epigenetics 2012, 7:535-541.
23. Nordlund J., Milani L., Lundmark A., Lonnerholm G., Syvanen A.C. DNA methylation analysis of bone marrow cells at diagnosis of acute lymphoblastic leukemia and at remission. PLoS One 2012, 7:e34513.
24. Figueroa M.E., Chen S.C., Andersson A.K., Phillips L.A., Li Y.S., Sotzen J., et al. Integrated genetic and epigenetic analysis of childhood acute lymphoblastic leukemia. J. Clin. Invest. 2013, 123:3099-3111.
25. Nordlund J., Backlin C.L., Wahlberg P., Busche S., Berglund E.C., Eloranta M.L., et al. Genome-wide signatures of differential DNA methylation in pediatric acute lymphoblastic leukemia. Genome Biol. 2013, 14:r105.
26. Milani L., Lundmark A., Nordlund J., Kiialainen A., Flaegstad T., Jonmundsson G., et al. Allele-specific gene expression patterns in primary leukemic cells reveal regulation of gene expression by CpG site methylation. Genome Res. 2009, 19:1-11.
27. Flotho C., Claus R., Batz C., Schneider M., Sandrock I., Ihde S., Plass C., Niemeyer C.M., Lubbert M. The DNA methyltransferase inhibitors azacitidine, decitabine and zebularine exert differential effects on cancer gene expression in acute myeloid leukemia cells. Leukemia 2009, 23:1019-1028.
28. Kohli R.M., Zhang Y. TET enzymes, TDG and the dynamics of DNA demethylation. Nature 2013, 502:472-479.
29. Song C.X., He C. Potential functional roles of DNA demethylation intermediates. Trends Biochem. Sci. 2013, 38:480-484.
30. Lorsbach R.B., Moore J., Mathew S., Raimondi S.C., Mukatira S.T., Downing J.R. TET1, a member of a novel protein family, is fused to MLL in acute myeloid leukemia containing the t(10;11)(q22;q23). Leukemia 2003, 17:637-641.
31. Solary E., Bernard O.A., Tefferi A., Fuks F., Vainchenker W. The Ten-Eleven Translocation-2 (TET2) gene in hematopoiesis and hematopoietic diseases. Leukemia 2014, 28:485-496.
32. Pronier E., Delhommeau F. Role of TET2 mutations in myeloproliferative neoplasms. Curr. Hematol. Malig. Rep. 2012, 7:57-64.
33. Langemeijer S.M.C., Kuiper R.P., Berends M., Knops R., Aslanyan M.G., Massop M., et al. Acquired mutations in TET2 are common in myelodysplastic syndromes. Nat. Gen. 2009, 41:838-U102.
34. Quivoron C., Couronne L., Della Valle V., Lopez C.K., Plo I., Wagner-Ballon O., et al. TET2 Inactivation results in pleiotropic hematopoietic abnormalities in mouse and is a recurrent event during human lymphomagenesis. Cancer Cell 2011, 20:25-38.
35. Cortellino S., Xu J., Sannai M., Moore R., Caretti E., Cigliano A., et al. Thymine DNA glycosylase is essential for active DNA demethylation by linked deamination-base excision repair. Cell 2011, 146:67-79.
36. Bhutani N., Burns D.M., Blau H.M. DNA demethylation dynamics. Cell 2011, 146:866-872.
37. Nabel C.S., Jia H., Ye Y., Shen L., Goldschmidt H.L., Stivers J.T., Zhang Y., Kohli R.M. AID/APOBEC deaminases disfavor modified cytosines implicated in DNA demethylation. Nat. Chem. Biol. 2012, 8:751-758.
38. Nabel C.S., Manning S.A., Kohli R.M. The curious chemical biology of Cytosine: deamination, methylation, and oxidation as modulators of genomic potential. ACS Chem. Biol. 2012, 7:20-30.
39. Muramatsu M., Sankaranand V.S., Anant S., Sugai M., Kinoshita K., Davidson N.O., et al. Specific expression of activation-induced cytidine deaminase (AID), a novel member of the RNA-editing deaminase family in germinal center B cells. J. Biol. Chem. 1999, 274:18470-18476.
40. Peled J.U., Kuang F.L., Iglesias-Ussel M.D., Roa S., Kalis S.L., Goodman M.F., et al. The biochemistry of somatic hypermutation. Annu. Rev. Immunol. 2008, 26:481-511.
41. Rada C., Williams G.T., Nilsen H., Barnes D.E., Lindahl T., Neuberger M.S. Immunoglobulin isotype switching is inhibited and somatic hypermutation perturbed in UNG-deficient mice. Curr. Biol. 2002, 12:1748-1755.
42. Di Nola J.M., Neuberger M.S. Molecular mechanisms of antibody somatic hypermutation. Ann. Rev. Biochem. 2007, 76:1-22.
43. Okazaki I.M., Hiai H., Kakazu N., Yamada S., Muramatsu M., Kinoshita K., et al. Constitutive expression of AID leads to tumorigenesis. J. Exp. Med. 2003, 197:1173-1181.
44. Liu M., Schatz D.G. Balancing AID and DNA repair during somatic hypermutation. Trends Immunol. 2009, 30:173-181.
45. Inaba H., Greaves M., Mullighan C.G. Acute lymphoblastic leukaemia. Lancet 2013, 381:1943-1955.
46. Matsumoto Y., Marusawa H., Kinoshita K., Endo Y., Kou T., Morisawa T., et al. Helicobacter pylori infection triggers aberrant expression of activation-induced cytidine deaminase in gastric epithelium. Nat. Med. 2007, 13:470-476.
47. Greeve J., Philipsen A., Krause K., Klapper W., Heidorn K., Castle B.E., et al. Expression of activation-induced cytidine deaminase in human B-cell non-Hodgkin lymphomas. Blood 2003, 101:3574-3580.
48. Klemm L., Duy C., Iacobucci I., Kuchen S., von Levetzow G., Feldhahn N., et al. The B cell mutator AID promotes B lymphoid blast crisis and drug resistance in chronic myeloid leukemia. Cancer Cell 2009, 16:232-245.
49. Pasqualucci L., Neumeister P., Goossens T., Nanjangud G., Chaganti R.S.K., Kuppers R., et al. Hypermutation of multiple proto-oncogenes in B-cell diffuse large-cell lymphomas. Nature 2001, 412:341-346.
50. Liu M., Duke J.L., Richter D.J., Vinuesa C.G., Goodnow C.C., Kleinstein S.H., et al. Two levels of protection for the B cell genome during somatic hypermutation. Nature 2008, 451:841-U11.
51. Feldhahn N., Henke N., Melchior K., Duy C., Soh B.N., Klein F., et al. Activation-induced cytidine deaminase acts as a mutator in BCR-ABL1-transformed acute lymphoblastic leukemia cells. J. Exp. Med. 2007, 204:1157-1166.
52. Gruber T.A., Chang M.S., Sposto R., Muschen M. Activation-induced cytidine deaminase accelerates clonal evolution in BCR-ABL1-driven B-cell lineage acute lymphoblastic leukemia. Cancer Res. 2010, 70:7411-7420.
53. Pui C., Relling M.V., Downing J.R. Mechanisms of disease: acute lymphoblastic leukemia. N. Engl. J. Med. 2004, 350:1535-1548.
54. Iacobucci I., Lonetti A., Messa F., Ferrari A., Cilloni D., Soverini S., et al. Different isoforms of the B-cell mutator activation-induced cytidine deaminase are aberrantly expressed in BCR-ABL1-positive acute lymphoblastic leukemia patients. Leukemia 2010, 24:66-73.
55. Refsland E.W., Harris R.S. The APOBEC3 family of retroelement restriction factors. Curr. Top. Microbiol. Immunol. 2013, 371:1-27.
56. Burns M.B., Temiz N.A., Harris R.S. Evidence for APOBEC3B mutagenesis in multiple human cancers. Nat. Gen. 2013, 45:977-983.
57. Wiemels J.L., Hofmann J., Kang M., Selzer R., Green R., Zhou M., et al. Chromosome 12p deletions in TEL-AML1 childhood acute lymphoblastic leukemia are associated with retrotransposon elements and occur postnatally. Cancer Res. 2008, 68:9935-9944.
58. Alexandrov L.B., Nik-Zainal S., Wedge D.C., Aparicio S.A.J.R., Behjati S., Biankin A.V., et al. Signatures of mutational processes in human cancer. Nature 2013, 500:415-421.
59. Greaves M.F., Maia A.T., Wiemels J.L., Ford A.M. Leukemia in twins: lessons in natural history. Blood 2003, 102:2321-2333.
60. Beumer J.H., Parise R.A., Newman E.M., Doroshow J.H., Synold T.W., Lenz H.J., Egorin M.J. Concentrations of the DNA methyltransferase inhibitor 5-fluoro-2'-deoxycytidine (FdCyd) and its cytotoxic metabolites in plasma of patients treated with FdCyd and tetrahydrouridine (THU). Cancer Chemother. Pharmacol. 2008, 62:363-368.
61. Shlomai J., Kornberg A. Deoxyuridine triphosphatase of Escherichia coli - purification, properties, and use as a reagent to reduce uracil incorporation into DNA. J. Biol. Chem. 1978, 253:3305-3312.